CongressMed is pleased to announce that the 3rd Congress on Controversies in Thrombosis and Hemostasis (CiTH) will be held in collaboration with the Russian Scientific Society of Clinical Hemostasiology in Moscow, Russia on October 20 – 22, 2016 at the Holiday Inn Moscow Sokolniki.
The 3rd edition of this ‘concept congress’ will continue to deal with controversial issues in the field, in the format of debates and discussions allowing ample time for speaker-participant interaction. By attending the congress participants will have the opportunity to attend two congresses in one, as the 2016 CiTH Congress will be held jointly with the 8th Russian Conference on Clinical Hemostasis and Hemorheology. All sessions will be simultaneously translated from/to Russian and English.
Congresses are becoming more and more specialized and monothematic, allowing limited time to fully discuss clinical meaning and the line between evidence based medicine (EBM) and working theories or ideas that are premature to implement into practice. CiTH addresses this need by facilitating effective debate on unresolved clinical and therapeutic dilemmas, supported by expert opinions resulting in agreement on timely issues.
The ability to discuss controversial topics with emphasis on clinical solutions in cases where no agreed-upon answers exist provides clinicians with an insight and a take-home message that ameliorates treatment in the most difficult situations.
- Thrombosis in oncology and oncohematology
- Thrombosis and hemorrhage in obstetrics
- Thrombosis and hemorrhage in surgery and traumatology-orthopedics
- Coagulation disorders in ICU
- Pathology of platelet-mediated hemostasis and vascular wall. Antiplatelet and angioprotective agents
- Venous thromboembolism
- Hemocoagulation problems in pediatrics and neonatology
- Arterial and venous thrombosis in cardiology and neurology
- Organ blood flow disorders, microcirculation and blood rheology
- Warfarin and new oral anticoagulant. New indications for NOAK
- Heparins: past, present and future
- Clinical transfusiology and hemostasis disorders
- Acute bleeding, care and preventions. Patient’s blood management
- Hemophilia. Thrombocytopathias. Von Willebrand Disease
- An Update on Laboratory Diagnostics in hemostasis and hemorheology
- Autoimmune diseases and pathology of hemostasis
- New tools for diagnosis, therapy and prevention of hemostasis disorders and blood rheology disturbances
- Thrombolytic therapy
- Basic research for clinical practice
Young Scientist Award
Who is eligible to enter?
Physicians, scientists & researchers born in 1981 or after
What is this competition all about?
The Scientific Committee of the Congress on Controversies in Thrombosis and Hemostasis (CiTH) invites young scientists or researchers to submit their work and to join the Young Scientist Award competition. The winner(s) will receive free registration and the abstract will be presented as an oral presentation.
Wow! How do I enter? It’s very simple.
- Submit your abstract via the Congress website.
- Register and pay registration fees (If your abstract is selected as a winner, your full registration fees will be refunded).
- Include your date of birth during the registration process.
Great! So what are the guidelines for submitting?
- Submitters must be born in 1981 or after.
- Submitters must be the first author of the abstract.
- Attendance at the CiTH Congress by the winner is mandatory in order to receive and collect the award.
- Winner(s) who cancel for any reason will not be entitled to collect their award.
- Benjamin Brenner, Israel – Rambam Medical Center
- Marco Cattaneo, Italy – University of Milan
- Anna Falanga, Italy – Hospital Papa Giovanni XXIII
- Kathelijn Fischer, Netherlands – University Medical Center Utrecht
- Jean Gris, France – University Hospital of Nîmes
- Gili Kenet, Israel – Tel Aviv University
- Ton Lisman, Netherlands – University Medical Center Groningen
- Aharon Lubetsky, Israel – Sheba Medical Center
- Pier M.Mannucci, Italy – Hospital Cà Granda
- Alan Michelson, USA – Harvard Medical School
- Paolo Prandoni, USA – University of Padua
- Shoshana Revel-Vilk, Israel – Hadassah Medical School
- Peter Verhamme, Belgium – University of Leuven
- Heleen Van Ommen, Belgium – University of Leuven
- David Varon, Israel – Hebrew University Medical Center